HOME
ABOUT US
CONTACT US
IPO
Vetted Prospectus
IPO Information
IPO Utilization Report
IPO Related Published News
PRODUCTS
Tablet
ANNUAL REPORTS
INVESTOR RELATIONS
Unclaimed / Unsettled Dividend
CG Compliance Status
Corporate Brief
Director's Report
Quarterly Report
Audited Financial Statements
Dividend Distribution Policy
Code of Conduct
Annual General Meeting
PRICE SENSITIVE INFORMATION (PSI)
Code of Conduct
MEDIA
CAREER
WEBMAIL
LOGIN
Products
See All
Tablet
Tablet I-Pedom 10mg
Domperidone Maleate BP,
Tablet
Tablet Indophylline 100mg
Aminophylline BP,
Tablet Sulbumol Plus 4.0mg
Salbutamol Sulphate BP,
Tablet Sulbumol 2.0mg
Salbutamol Sulphate BP,
Tablet Albendox 400mg
Albendazole USP ,
Tablet Mebendox 100mg
Mebendazole BP ,
Tablet I-Fol Plus
Ferrous Fumarate & Folic Acid ,
Tablet I-Fol
Ferrous Fumarate & Folic Acid,
Tablet Indosin
Chlorpheniramine Maleate BP ,
Tablet Indo-Fila 100mg
Diethylcarbamazine Citrate BP ,
Tablet Indomol Plus
Paracetamol BP Caffeine BP,
Tablet Trialugel
Aluminium Hydroxide Dried Gel BP Magnesium Hydroxide BP,
Tablet I–Cet 10mg
Cetirizine Hydrochloride BP,